We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
- Authors
Karmali, Reem; Kassar, Mohamad; Venugopal, Parameswaran; Shammo, Jamile M; Fung, Henry C; Bayer, Robert; O'Brien, Teresa; Gregory, Stephanie A
- Abstract
We conducted a single-institution phase II clinical trial evaluating the safety and efficacy of combination chemoimmunotherapy followed by radioimmunotherapy consolidation and rituximab maintenance as front-line treatment in indolent lymphomas.
- Publication
Clinical lymphoma, myeloma & leukemia, 2011, Vol 11, Issue 6, p467
- ISSN
2152-2669
- Publication type
Journal Article
- DOI
10.1016/j.clml.2011.04.009